Imax Corp
IMAX- Exchange
- NYSE
- Industry
- Photographic Equipment & Supplies
- SEC CIK
- 0000921582
In the last 90 days, Imax Corp insiders filed 0 open-market purchases and 6 sales; 260 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:35 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 25, 2026 | Feb 19, 2025 | Feb 27, 2024 | Feb 22, 2023 | Feb 23, 2022 |
| Revenue | $410.2M | $352.2M | $374.8M | $300.8M | $254.9M |
| Cost of revenue | $164.0M | $162.0M | $160.5M | $144.4M | $120.5M |
| Gross profit | $246.2M | $190.2M | $214.3M | $156.4M | $134.4M |
| Research and development | $5.82M | $5.10M | $10.1M | $5.30M | $6.94M |
| Selling, general and administrative | $138.5M | $132.7M | $144.4M | $138.0M | – |
| Operating income | $84.2M | $43.9M | $50.4M | -$4.83M | $11.0M |
| Interest expense | – | – | $6.82M | $5.88M | $7.09M |
| Income tax | $17.8M | $5.00M | $13.1M | $10.1M | $20.6M |
| Net income | $34.9M | $26.1M | $25.3M | -$22.8M | -$22.3M |
| EPS, basic | $0.65 | $0.49 | $0.47 | $-0.40 | – |
| EPS, diluted | $0.63 | $0.48 | $0.46 | $-0.40 | – |
| Weighted shares, basic | 53.6M | 52.6M | 54.3M | 56.7M | 59.1M |
| Weighted shares, diluted | 55.5M | 53.9M | 55.1M | 56.7M | 59.1M |
| Margins and growth | |||||
| Gross margin | 60.0% | 54.0% | 57.2% | 52.0% | 52.7% |
| Operating margin | 20.5% | 12.5% | 13.4% | -1.6% | 4.3% |
| Net margin | 8.5% | 7.4% | 6.8% | -7.6% | -8.8% |
| Revenue growth, year over year | +16.5% | −6.0% | +24.6% | +18.0% | +86.0% |
| Net income growth, year over year | +33.8% | +2.9% | – | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 25, 2026 | Feb 19, 2025 | Feb 27, 2024 | Feb 22, 2023 | Feb 23, 2022 |
| Cash and equivalents | $151.2M | $100.6M | $76.2M | $97.4M | $189.7M |
| Accounts receivable | $108.1M | $107.7M | $136.3M | $136.1M | $110.0M |
| Inventory | $32.5M | $32.8M | $31.6M | $31.5M | $26.9M |
| Property, plant and equipment | $242.9M | $240.1M | $243.3M | $252.9M | $260.4M |
| Goodwill | $45.8M | $52.8M | $52.8M | $52.8M | $39.0M |
| Intangible assets | $32.4M | $35.1M | $35.0M | $32.7M | $23.1M |
| Total assets | $894.0M | $830.4M | $814.7M | $821.2M | $883.2M |
| Long-term debt | – | – | – | – | $2.47M |
| Total liabilities | $466.3M | $452.2M | $469.1M | $491.4M | $452.9M |
| Shareholders' equity | $427.1M | $377.5M | $344.9M | $329.0M | $429.6M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 25, 2026 | Feb 19, 2025 | Feb 27, 2024 | Feb 22, 2023 | Feb 23, 2022 |
| Operating cash flow | $127.1M | $70.8M | $58.6M | $17.3M | $6.07M |
| Capital expenditures | $8.17M | $8.43M | $6.49M | $8.42M | $3.59M |
| Free cash flow | $118.9M | $62.4M | $52.1M | $8.90M | $2.48M |
| Depreciation and amortization | $62.4M | $65.5M | $60.0M | $56.7M | $56.1M |
| Stock-based compensation | $26.6M | $22.8M | $23.6M | $27.0M | $25.6M |
| Share buybacks | – | – | – | – | $13.9M |
| Investing cash flow | -$41.9M | -$41.2M | -$31.8M | -$53.3M | -$7.00K |
| Financing cash flow | -$34.1M | -$6.04M | -$48.5M | -$58.5M | -$132.7M |
| Net change in cash | $50.6M | $24.4M | -$21.2M | -$92.3M | -$127.7M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 6.5% | 6.5% | 6.3% | 9.0% | 10.0% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.